cardiovascular benefits of glp-1 Agonists in Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies Revolutionary heart health benefits beyond

"Efficacy and Safety of Cagrilintide Alone and in Combination with Semaglutide (Cagrisema) as Anti-Obesity Medications: A Systematic Review and Meta-Analysis"

Easing GLP-1 Side Effects: Informed Relief for Nausea and Constipation Executive Summary Executive Summary Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have revolutionized the treatment of type 2 diabetes and obesity and are now among the most prescribed medications for use in adults with these conditions [1]

The authors acknowledge financial support from the Fund for Scientific ResearchFlanders (project number G012413N)

NotCo Review: Does it Taste Like a Burger